Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer-Reference-Cited by-同舟云学术

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer

Published:2017-08-18 Issue:1 Volume:3 Page:
ISSN:2374-4677
Container-title:npj Breast Cancer
language:en
Short-container-title:npj Breast Cancer

Author:

Speers Corey^ORCID,Zhao Shuang G.,Chandler Ben,Liu Meilan,Wilder-Romans Kari,Olsen Eric,Nyati Shyam,Ritter Cassandra,Alluri Prasanna G.,Kothari Vishal,Hayes Daniel F.,Lawrence Theodore S.,Spratt Daniel E.,Wahl Daniel R.,Pierce Lori J.,Feng Felix Y.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology

Link

http://www.nature.com/articles/s41523-017-0038-2.pdf

Reference27 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics. CA: A Cancer Journal for Clinicians. 67, 7–30 (2017).

2. Lowery, A. J., Kell, M. R., Glynn, R. W., Kerin, M. J. & Sweeney, K. J. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res. Treat. 133, 831–841 (2012).

3. Kyndi, M. et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J. Clin. Oncol. 26, 1419–1426 (2008).

4. Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429–4434 (2007).

5. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750–2767 (2011).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Changes in Breast Cancer Induced by Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.;Cancer Letters;2024-09

3. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway;Journal of Experimental & Clinical Cancer Research;2024-07-20

4. Androgens in cervical cancer: Their role in epidemiology and biology;iScience;2024-07

5. Innovative therapeutic strategies to overcome radioresistance in breast cancer;Frontiers in Oncology;2024-05-30